Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a newer version of the MARIPOSA-2 study page.
    Difference
    0.0%
    Check dated 2026-09-03T18:32:54.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A new entry '2023 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, updating the record's funding metadata.
    Difference
    0.0%
    Check dated 2026-08-27T15:50:34.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The study timeline metadata was updated, with two date entries added and two removed, affecting milestone and update timestamps shown on the study record.
    Difference
    0.1%
    Check dated 2026-08-20T13:56:00.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision 3.6.5 has been added, replacing 3.6.4, indicating a minor update to the page's metadata/versioning rather than user-visible content.
    Difference
    0.0%
    Check dated 2026-08-13T11:41:07.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page’s revision history has been updated with new update dates (2026-07-30, 2028-03-01, 2026-07-02, 2026-07). Some older dates have been removed (2026-06-08, 2027-11-30, 2026-06-04, 2026-06).
    Difference
    0.1%
    Check dated 2026-08-06T09:40:03.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, signaling a content update to the study details page.
    Difference
    0.0%
    Check dated 2026-07-23T09:21:13.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.